icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Comparative Resistance Analysis Between Cirrhotic and Non-cirrhotic Treatment Experienced Patients Who Failed Treatment With a Combination of Vaniprevir (MK-7009) and Pegylated Interferon and Ribavirin (P/R)
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Steve Ludmerer, Richard Barnard, Stuart Black, Joann Brunhoffer, Anita Howe, Peggy May Tan Hwang, Rong Liu, Amy Zhou, and Niloufar Mobashery Merck & Co., Inc., Whitehouse Station, NJ, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif